PMID- 17308101 OWN - NLM STAT- MEDLINE DCOM- 20070315 LR - 20211203 IS - 0008-5472 (Print) IS - 1538-7445 (Electronic) IS - 0008-5472 (Linking) VI - 67 IP - 4 DP - 2007 Feb 15 TI - TSC1 sets the rate of ribosome export and protein synthesis through nucleophosmin translation. PG - 1609-17 AB - Nucleophosmin (B23) is a nucleolar phosphoprotein that has been implicated in numerous cellular processes. In particular, nucleophosmin interacts with nucleolar components of newly synthesized ribosomes to promote ribosome nuclear export. Nucleophosmin is a classic mitogen-induced protein, with changes in its expression correlating with growth factor stimulation. In this study, we examined the underlying mechanism of nucleophosmin induction and showed that hyperproliferative signals emanating from oncogenic H-Ras(V12) cause tremendous increases in nucleophosmin protein expression. Nucleophosmin protein accumulation was dependent on mammalian target of rapamycin (mTOR) activation, as rapamycin completely prevented nucleophosmin induction. Consistent with this finding, genetic ablation of Tsc1, a major upstream inhibitor of mTOR, resulted in nucleophosmin protein induction through increased translation of existing nucleophosmin mRNAs. Increases in nucleophosmin protein accumulation were suppressed by reintroduction of TSC1. Induction of nucleophosmin through Tsc1 loss resulted in a greater pool of actively translating ribosomes in the cytoplasm, higher overall rates of protein synthesis, and increased cell proliferation, all of which were dependent on efficient nucleophosmin nuclear export. Nucleophosmin protein accumulation in the absence of Tsc1 promoted the nuclear export of maturing ribosome subunits, providing a mechanistic link between TSC1/mTOR signaling, nucleophosmin-mediated nuclear export of ribosome subunits, protein synthesis levels, and cell growth. FAU - Pelletier, Corey L AU - Pelletier CL AD - Division of Molecular Oncology, Department of Internal Medicine, Siteman Cancer Center, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO 63110, USA. FAU - Maggi, Leonard B Jr AU - Maggi LB Jr FAU - Brady, Suzanne N AU - Brady SN FAU - Scheidenhelm, Danielle K AU - Scheidenhelm DK FAU - Gutmann, David H AU - Gutmann DH FAU - Weber, Jason D AU - Weber JD LA - eng GR - GM 066032/GM/NIGMS NIH HHS/United States GR - U01 CA 84314/CA/NCI NIH HHS/United States GR - T32 GM007200/GM/NIGMS NIH HHS/United States GR - 5T32 GM 07200/GM/NIGMS NIH HHS/United States GR - R01 GM066032/GM/NIGMS NIH HHS/United States GR - R01 GM066032-05/GM/NIGMS NIH HHS/United States GR - U01 CA084314/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, Non-P.H.S. PL - United States TA - Cancer Res JT - Cancer research JID - 2984705R RN - 0 (Chromones) RN - 0 (Morpholines) RN - 0 (NPM1 protein, human) RN - 0 (Npm1 protein, mouse) RN - 0 (Nuclear Proteins) RN - 0 (Platelet-Derived Growth Factor) RN - 0 (RNA, Messenger) RN - 0 (TSC1 protein, human) RN - 0 (Tsc1 protein, mouse) RN - 0 (Tuberous Sclerosis Complex 1 Protein) RN - 0 (Tumor Suppressor Proteins) RN - 117896-08-9 (Nucleophosmin) RN - 31M2U1DVID (2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one) RN - EC 2.7.- (Protein Kinases) RN - EC 2.7.1.1 (MTOR protein, human) RN - EC 2.7.1.1 (mTOR protein, mouse) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) RN - EC 3.6.5.2 (ras Proteins) RN - W36ZG6FT64 (Sirolimus) SB - IM MH - Animals MH - Chromones/pharmacology MH - Humans MH - Mice MH - Morpholines/pharmacology MH - Nuclear Proteins/biosynthesis/genetics/*metabolism MH - Nucleophosmin MH - Platelet-Derived Growth Factor/pharmacology MH - Protein Biosynthesis MH - Protein Kinases/metabolism MH - RNA, Messenger/biosynthesis/genetics MH - Ribosomes/*metabolism MH - Sirolimus/pharmacology MH - TOR Serine-Threonine Kinases MH - Tuberous Sclerosis Complex 1 Protein MH - Tumor Suppressor Proteins/deficiency/genetics/*metabolism MH - ras Proteins/metabolism PMC - PMC2859708 MID - NIHMS47495 EDAT- 2007/02/20 09:00 MHDA- 2007/03/16 09:00 PMCR- 2010/04/26 CRDT- 2007/02/20 09:00 PHST- 2007/02/20 09:00 [pubmed] PHST- 2007/03/16 09:00 [medline] PHST- 2007/02/20 09:00 [entrez] PHST- 2010/04/26 00:00 [pmc-release] AID - 67/4/1609 [pii] AID - 10.1158/0008-5472.CAN-06-2875 [doi] PST - ppublish SO - Cancer Res. 2007 Feb 15;67(4):1609-17. doi: 10.1158/0008-5472.CAN-06-2875.